Luke Evnin, Director at Werewolf Therapeutics, Inc. (HOWL), sold 111,227 shares at $0.55 ($62K) on 2026-01-13, disclosed to the SEC on 2026-01-15.
Open-market sale of $62k HOWL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.55 | 43,198 | $24K | 38.5% |
| 2 | $0.57 | 30,616 | $17K | 28.2% |
| 3 | $0.55 | 37,413 | $21K | 33.3% |
| Total | $0.56 avg | 111,227 | $62K | 100% |
| Filing → |
| HOWL | SELL | 2026-06-10 | $28K | — | Filing → |
| HOWL | SELL | 2026-06-08 | $43K | — | Filing → |
| HOWL | SELL | 2026-06-03 | $64K | — | Filing → |